Introduction
A recurring question in neurodevelopmental research and clinical practice is whether attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are “the same” condition or fundamentally different disorders.[1] Diagnostic descriptions have historically emphasized differences, with one review noting that “based on their diagnostic descriptions” ADHD and ASD “have little in common.”[2] At the same time, the view that the two conditions can meaningfully co-occur has become “commonly believed,” and the co-occurrence is argued to be clinically and etiologically informative rather than merely an artifact.[2, 3]
A key nosological change enabling systematic study of co-occurrence is that earlier diagnostic systems did not allow concurrent diagnosis, whereas DSM-5 lifted that prohibition.[3, 4] This diagnostic shift is explicitly described in both clinical and genetics-focused reviews as an important step in acknowledging real-world clinical presentations where both sets of symptoms are present and impairing.[3, 5]
Overlap
Clinical overlap between ADHD and ASD is supported by consistently high comorbidity estimates and by evidence that the comorbid presentation is often more severe than either condition alone.[3] Reviews emphasize that comorbidity is not readily explained away by “diagnostic or phenotypic overlap” alone, suggesting that shared liabilities may be involved.[6]
Prevalence estimates vary by sampling and ascertainment, but several reviews place ADHD as the most common comorbidity in children with ASD, with rates reported in the 40–70% range.[3] Conversely, a “substantial minority” of youth with ADHD (15–25%) show ASD traits, with one estimate reporting 12.4% having an ASD diagnosis.[3] An epidemiologically based estimate cited in a selective review reports around 30% prevalence of comorbid ADHD in ASD and emphasizes that this rate is approximately six times higher than worldwide ADHD prevalence estimates, “preclud[ing]” co-occurrence “by chance.”[7]
Symptom overlap creates practical diagnostic challenges even when formal criteria are non-overlapping, because inattentive and hyperactive symptoms are “often reported in individuals with ASD,” and social interaction problems are commonly reported in ADHD.[7] Recent synthesis work further highlights that “shared symptoms, particularly inattention and executive dysfunction,” can complicate differential diagnosis and delay accurate identification, with downstream effects on treatment effectiveness.[8]
Longitudinal and subgrouping approaches suggest that overlap is partly organized at the “person” level (i.e., subgroups with co-occurring symptom elevations) rather than at the level of a single shared symptom factor.[9] A scoping review reports that most factor-analytic studies found ASD and ADHD symptom domains loading separately, while latent class studies consistently identified subgroups with co-occurring elevated symptoms meeting clinical thresholds.[9] Complementary questionnaire-based longitudinal work reports that children with comorbid ASD+ADHD have the “most severe symptoms” that “persisted over development,” while single-diagnosis groups showed more moderate symptoms that improved with age.[10]
The comorbid presentation is repeatedly described as more impairing, with one management-focused review stating the comorbid state is “almost universally” more impairing than ADHD or ASD alone.[3] A cohort comparison similarly finds that the ASD+ADHD group differs from ASD-only or ADHD-only in some domains (e.g., lower mean IQ and higher autistic symptom severity) while also sharing inattention and hyperactivity with ADHD and adaptive impairment with ASD.[11]
Genetics
Across decades of behavioral genetic and molecular genetic work, the dominant empirical picture is that ADHD and ASD share genetic influences but also show differentiating genetic architecture.[2, 12] Family and twin studies are summarized as supporting the hypothesis that ADHD and ASD “originate from partly similar familial/genetic factors,” and a review argues that the “most likely model” is that the disorders “partly shared a common genetic basis.”[2] A behavioral-genetic synthesis likewise states that ASD and ADHD are “two different groups of disorders” but “do not appear quite so dissimilar at the genetic level,” with twin studies suggesting “a considerable degree” of shared genetic influences.[13]
Shared common variant signal
Molecular genetic syntheses and cross-disorder analyses converge on a moderate common-variant genetic correlation between ASD and ADHD, often reported around .[5, 12] A 2020 multivariate genomic study reports that Genomic SEM identified 7 genome-wide significant shared SNPs between ASD and ADHD, including SNPs not identified in the original univariate GWAS.[14] The same study reports substantial colocalization, with 44% of ASD-associated SNPs (at ) colocalizing with ADHD SNPs and 26% of ADHD-associated SNPs colocalizing with ASD SNPs.[14]
Bidirectional Mendelian randomization (MR) analyses in that multivariate genomic work report reciprocal associations between genetic liability for ASD and ADHD, with ASD liability associated with increased ADHD risk () and ADHD liability associated with increased ASD risk ().[14]
Shared and differentiating loci
Large cross-disorder GWAS studies explicitly model both shared and differentiating genetic liability.[12] One such study reports identifying “seven loci shared by the disorders and five loci differentiating them,” with “lead variants” showing “opposite directions of effects” between ADHD and ASD.[12] The same work emphasizes that comorbid cases can be “double-burdened with both ASD and ADHD PRS,” suggesting that at least some comorbidity reflects additive polygenic loading rather than diagnostic artifact.[12]
A related cross-disorder genetic architecture analysis similarly finds seven shared loci and five differentiating loci and reports that the ASD polygenic score load in ASD+ADHD cases is similar to ASD-only cases, and the ADHD polygenic score load in ASD+ADHD cases is similar to ADHD-only cases, implying the comorbid subgroup carries substantial liability for both conditions.[15]
Dimension-specific overlap and candidate mechanisms
Twin and population approaches indicate that overlap is often dimension-specific rather than uniform across all ASD and ADHD domains.[16] In adult twin data, restricted and repetitive behaviors and interests (ASDr) show the strongest associations with both ADHD inattention and hyperactivity/impulsivity, and genetic correlations are reported as strongest between ASDr and ADHD dimensions (approximately ).[16] In a population-based twin analysis of autistic-like traits (ALTs), social-communication ALTs show substantial genetic correlation with ADHD inattention () and hyperactivity-impulsivity ().[17]
Candidate phenotypic mechanisms have also been proposed as “bridging” features.[18] Reaction time variability (RTV) is described as a bridging factor in systematic review work and shows a moderate genetic correlation with social-communication ALTs (), accounting for an estimated 24% of the genetic covariance between inattention and social-communication ALTs in one twin study.[17, 18]
At the level of specific genes, SHANK2 is repeatedly highlighted as a potential pleiotropic contributor to both disorders.[6, 18] A candidate-gene association study reports significant association for multiple SHANK2 SNPs with both ADHD and ASD and describes protective alleles decreasing risk of both disorders by around 20–30%, concluding that SHANK2 may be a “potential pleiotropic gene” for the two disorders.[6]
Neurobiology
Neurobiological evidence, particularly from neuroimaging, also supports a mixed picture of shared and disorder-specific features rather than identity.[3] A clinical management review summarizes neuroimaging patterns suggesting ASD is associated with increased total brain volume and amygdala overgrowth, while ADHD is associated with reduced total brain volume and reduced white matter fractional anisotropy (FA) in the internal capsule.[3] The same synthesis notes shared features such as lower volumes and reduced FA in the corpus callosum and cerebellum and reduced FA in the superior longitudinal fasciculus.[3]
Resting-state fMRI evidence similarly indicates both shared and distinct network-level abnormalities.[19] A voxelwise functional network centrality study reports disorder-specific patterns, including ADHD-related increases in degree centrality in right striatum/pallidum versus ASD-related increases in temporolimbic areas, while shared abnormalities based on primary diagnosis were “limited to precuneus.”[19] Importantly for comorbidity models, secondary analyses indicate that ASD children with ADHD-like comorbidity (ASD+) share ADHD-specific abnormalities in basal ganglia, implying that comorbidity may correspond to partially shared circuit-level signatures rather than a simple averaging of two unrelated profiles.[19]
Cognition
Cognitive findings align with the idea of overlap in broad domains (especially executive functioning and attention), alongside component-level differences between ADHD and ASD.[4] A systematic review focused on executive function components in comorbid presentations reports evidence for executive dysfunction across attention, response inhibition, and verbal working memory in children and adolescents with ASD and comorbid ADHD symptoms.[20] At a broader level, clinical management synthesis argues that even when executive functioning is disrupted in both disorders, the affected components can differ, with ADHD characterized by difficulties in inhibition and sustained attention while ASD is characterized by difficulties in planning and shifting attention.[3]
Developmental reviews propose attention as a key linking domain, while also emphasizing divergence in motivational and behavioral tendencies.[21] A review of early childhood work concludes that ASD and ADHD share high negative affect, but motivational mechanisms diverge (withdrawal in ASD vs approach in ADHD), and that both share difficulties with control and shifting while showing partly opposite behavioral tendencies.[21]
Person-centered cognitive profiling provides an additional angle on “same vs distinct.”[22] Latent class analyses of a cognitive battery in both population and clinic samples identified a shared four-class cognitive profile, and the authors report that “no cognitive subtype” was specifically related to ASD versus ADHD symptoms, interpreting this as support for the hypothesis that both disorders can be “expressions of one overarching disorder” in clinical populations.[22] The same study notes that such class–symptom associations were absent in the population sample, suggesting ascertainment and severity may moderate whether shared cognitive profiles map onto symptom burdens.[22]
Frameworks
Conceptual models in the reviewed literature typically reject strict identity (i.e., ADHD and ASD being literally the same disorder) while accommodating multiple sources of overlap.[1] One comorbidity framework explicitly lists the possibility that “two disorders are alternate manifestations of the same underlying risk factor(s),” positioning “sameness” as a theoretical option among others rather than a settled conclusion.[7] A genetics-focused review similarly notes that inflated co-occurrence rates can arise from overlapping diagnostic criteria, but argues that a shared common genetic basis is the more likely explanation.[2]
Several models are compatible with the co-existence of shared liability and disorder-specific structure.[9] The scoping review of latent structure highlights that ASD and ADHD domains often load separately in factor analytic studies (supporting distinct latent domains), while person-centered approaches identify latent subgroups with co-occurring symptoms (supporting overlap and shared liability in subsets).[9] Symptom-level work using gold-standard ASD measures provides further support for an additive model, reporting no ASD×ADHD interaction effects across most ADOS/ADI-R symptom domains and arguing that this pattern supports a model where ASD+ADHD reflects “a combination of the 2 distinct pathologies.”[23]
At the genomic level, pleiotropy is a unifying hypothesis for co-occurrence that can still allow net differences between disorders.[24] One polygenic analysis argues that “discordant” association profiles with educational attainment can be “encoded across the same polygenic sites” without invoking distinct loci, describing this as evidence for pleiotropic mechanisms.[24]
Recent hypotheses
Recent work (roughly 2019–2024 in the provided evidence) increasingly formalizes overlap as a combination of (i) shared neurodevelopmental liability, (ii) domain- and subgroup-specific overlap, and (iii) differentiating genetic architecture that may align with cognitive traits.[12, 16] Cross-disorder GWAS analyses that separate shared from differentiating loci provide a concrete instantiation of this view by showing both shared loci and differentiating loci with opposite directions of effect.[12] Within that same framework, comorbid cases are characterized as carrying both ASD and ADHD polygenic burdens, supporting an additive polygenic interpretation of at least part of the comorbid subgroup.[12]
A complementary hypothesis is that the axes differentiating ADHD and ASD genetic liability may be more strongly tied to cognition than the axes reflecting shared psychiatric liability.[12] In the cross-disorder study, the liability differentiating ADHD-vs-ASD shows strongest correlations with cognitive traits such as years of schooling () and childhood IQ (), whereas the combined liability shows strong correlations with depressive symptoms () and cross-disorder psychiatric GWAS signal ().[12]
Finally, some hypotheses extend beyond ADHD–ASD dyads toward broader dimensional models of neurodevelopment.[25] A head-to-head experimental study motivates a “continuum of neurodevelopmental impairment” based on evidence of genetic overlap and finds highly correlated profiles of deviation from controls between ADHD and ASD (vector correlation ), while also finding quantitative differences in overall impairment.[25]
Implications
Clinical guidance across the included reviews emphasizes that co-occurrence is common enough to warrant routine cross-screening and careful differential assessment.[8, 18] A genetics-focused systematic review explicitly recommends routinely screening for ADHD in ASD and vice versa “due to their genetic overlap,” linking clinical practice to etiological evidence.[18]
Treatment implications follow directly from recognizing comorbidity rather than excluding it diagnostically.[3, 4] Before DSM-5, the lack of permission to assign both diagnoses was argued to have “treatment implications” because individuals with ASD and ADHD symptoms might not be identified and could experience delayed or denied ADHD treatment.[4] A narrative review further argues that the idea ADHD cannot be diagnosed or treated in ASD “is a myth that should be dispelled,” stating that many with both conditions can “benefit greatly” from treating ADHD symptoms.[4]
Because co-occurring presentations are repeatedly associated with higher impairment and more persistent symptom burden, several sources argue for integrated or multidisciplinary care approaches.[3, 10] One recent review explicitly states that a multidisciplinary approach combining behavioral, cognitive, and pharmacological treatments “appears to be the most effective.”[26] More broadly, intervention approaches may differ across ASD and ADHD despite overlap, reinforcing the practical importance of distinguishing domains even when etiologic overlap exists.[5]
The table below summarizes how different levels of analysis bear on the “same vs distinct” question.
Conclusion
Across clinical, genetic, neurobiological, and cognitive lines of evidence, ADHD and ASD are best characterized as overlapping but distinct neurodevelopmental conditions rather than the same disorder.[1, 27] Reviews explicitly argue there is “some overlap” but “enough differences” to justify separate diagnostic categories and use an analogy that the conditions are “cousins” rather than “twins.”[1]
The strongest established findings support frequent comorbidity and substantial shared genetic liability, including moderate genetic correlations and shared loci, which argue against a purely artifactual explanation of co-occurrence.[3, 5] At the same time, disorder-differentiating loci, opposite directions of allelic effects, and component-level cognitive and neurobiological differences support the view that the two conditions are not identical and can diverge meaningfully in mechanisms and clinical needs.[3, 12, 19] The emerging consensus in the provided literature therefore favors a model in which shared neurodevelopmental risks and pleiotropy create overlap and comorbidity, while additional differentiating pathways contribute to distinct symptom profiles and outcomes.[12, 24]
